Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Datametrex AI (DM) currently has approximately $20M in cash and marketable securities on its balance sheet
  • Marshall Gunter, CEO of Datametrex sat down with Caroline Egan to discuss the news
  • This is equivalent to approximately $0.056 per share with the company’s current market cap of approximately $85M
  • Datametrex believes it will continue to see growth in revenue and profitability, generating stronger positive cash flow in 2022
  • Datametrex AI is a technology focused company with exposure to AI and machine learning
  • Datametrex AI Ltd. (DM) opened trading at $0.23 per share

Datametrex AI (DM) currently has approximately $20M in cash and marketable securities on its balance sheet.

Marshall Gunter, CEO of Datametrex sat down with Caroline Egan to discuss the news.

The cash balance is twenty times what it was valued in the same period of 2019. It is equivalent to approximately $0.056 per share with the company’s current market cap of approximately $85M.

Datametrex believes it will continue to see growth in revenue and profitability from its operations, generating stronger positive cash flow in 2022, further strengthening its cash position. 

“We are pleased with the great start to the year as we continue to make every effort to improve revenue and find efficiencies from the efforts made over the years. We look forward to delivering on greater cash flow in 2022,” said Marshall Gunter, CEO of Datametrex.

Chairman Andrew Ryu added,

“As we continue to grow the revenue and look to expand the company, we will also focus on operating as efficiently as possible, as it will allow us to meet the company’s objectives and produce value for our investors.” 

Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy.

Datametrex AI Limited (DM) opened trading at C$0.23 per share.

More From The Market Herald
The Market Herald Video

" Empower Clinics (CSE:CBDT) accredited for Covid-19 mobile testing in B.C.

Empower Clinics (CBDT) has received accreditation for its COVID-19 mobile testing solutions.

" @ the Bell: Financial & industrial shares move TSX higher

A solid rally among indices lifted Canada’s main stock index to another positive close on Thursday.
Converge Technology Corp - CEO, Shaun Maine

" Converge Technology (TSX:CTS) announces licensing agreement with IBM

Converge Technology (CTS) announced a licensing agreement with IBM to extend its cloud capabilities with Converge Enterprise Cloud on IBM Power for Google